Stent Clinical Trials

196 recruitingLast updated: June 18, 2026

There are 196 actively recruiting stent clinical trials across 39 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1, Early Phase 1. Top locations include New York, New York, United States, Beijing, Beijing Municipality, China, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Stent Trials at a Glance

196 actively recruiting trials for stent are listed on ClinicalTrialsFinder across 6 cities in 39 countries. The largest study group is Not Applicable with 95 trials, with the heaviest enrollment activity in New York, Beijing, and Boston. Lead sponsors running stent studies include Boston Scientific Corporation, Beijing Tiantan Hospital, and Abbott Medical Devices.

Treatments under study

About Stent Clinical Trials

Looking for clinical trials for Stent? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Stent trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Stent clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 196 trials

Recruiting
Not Applicable

PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)

Persistent Atrial Fibrillation
Boston Scientific Corporation640 enrolled1 locationNCT07106970
Recruiting
Not Applicable

Evaluation of the Efficacy of Pulmonary Vein Isolation by Pulsed-field Ablation in Persistent Atrial Fibrillation: a Multicenter Study With Follow-up by Implantable Cardiac Monitor

Persistent Atrial Fibrillation
Centre Hospitalier Universitaire de Nice60 enrolled1 locationNCT06985901
Recruiting
Not Applicable

An Ecological Momentary Intervention for the Reduction of Impairment in Somatic Symptom Disorder

Somatic Symptom Disorder (DSM-5)Persistent Physical SymptomsMedically Unexplained Symptoms+2 more
University of Vienna40 enrolled1 locationNCT07646509
Recruiting
Phase 3

An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED

Persistent Corneal Epithelial Defect
Dompé Farmaceutici S.p.A150 enrolled18 locationsNCT07519902
Recruiting
Not Applicable

ComfiJ Versus Conventional Double-J Stent for Ureteral Stent Symptoms

UrolithiasisUreteral CalculiUreteral Stent-Related Symptoms
Beni-Suef University150 enrolled3 locationsNCT07627828
Recruiting
Not Applicable

Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation

Persistent Atrial FibrillationParoxysmal Atrial Fibrillation (PAF)
Boston Scientific Corporation571 enrolled1 locationNCT07575269
Recruiting
Phase 2

Melatonin and Solifenacin for Double-J Ureteral Stent Symptoms

Lower Urinary Tract SymptomsUreteral CalculiUreteral Stent-Related Symptoms
Beni-Suef University189 enrolled1 locationNCT07617922
Recruiting
Not Applicable

Feasibility Study of the FARAFLEX Mapping and PFA System

Atrial FibrillationPersistent Atrial FibrillationParoxysmal AF
Boston Scientific Corporation250 enrolled4 locationsNCT06510556
Recruiting
Phase 1Phase 2

Dexamethasone for Ureteral STent Symptoms (DUSTS)

Ureteral Stent-Related Symptom
The Methodist Hospital Research Institute70 enrolled1 locationNCT06930690
Recruiting

RevCore for In Stent Thrombosis

In-stent Thrombosis
Inari Medical100 enrolled16 locationsNCT06394739
Recruiting
Not Applicable

Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial

Coronary Artery DiseaseDrug-eluting StentDrug-eluting Balloon
Translumina GmbH1,380 enrolled1 locationNCT07397845
Recruiting
Not Applicable

Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System

Persistent Atrial FibrillationParoxysmal Atrial Fibrillation
Boston Scientific Corporation200 enrolled4 locationsNCT07444320
Recruiting
Not Applicable

Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

Persistent Atrial Fibrillation
Boston Scientific Corporation376 enrolled40 locationsNCT06735534
Recruiting
Phase 2Phase 3

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Recurrent Cervical CancerMetastatic Cervical CancerPersistent Cervical Cancer
N.N. Alexandrov National Cancer Centre120 enrolled1 locationNCT07472153
Recruiting
Phase 1Phase 2

Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease

Post Operative PainUrolithiasisStent Complication+1 more
University of Texas Southwestern Medical Center80 enrolled1 locationNCT06158620
Recruiting
Not Applicable

Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration

Atrial Fibrillation (AF)Persistent Atrial FibrillationParoxysmal AF
Abbott Medical Devices240 enrolled13 locationsNCT07523620
Recruiting
Not Applicable

BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF

Atrial FibrillationAtrial ArrhythmiaPersistent Atrial Fibrillation+1 more
Abbott Medical Devices300 enrolled22 locationsNCT07181590
Recruiting
Not Applicable

Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

ThrombosisAmputationPlatelet Aggregation Inhibitors+4 more
Massachusetts General Hospital484 enrolled2 locationsNCT07613840
Recruiting
Not Applicable

A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatients

Treatment Resistant DepressionPersistent Depressive Disorder
University of Greifswald396 enrolled8 locationsNCT04996433
Recruiting
Not Applicable

Yoga for Persistent Post-Surgical Pain (PPSP)

Persistent Post-surgical Pain
Brigham and Women's Hospital50 enrolled1 locationNCT06949007